Skip to main content

Table 7 Two-fold relevancy prediction in terms of WSS@95% on DERP systematic review collections

From: Improving reference prioritisation with PICO recognition

 [84][119][95]LRPICOΔ
ACE Inhibitors52.373.3*80.178.577.6-0.9
ADHD62.252.6*79.375.574.5-0.9
Antihistamines14.9*23.613.74.95.00.1
Atypical Antipsychotics20.617.0*25.119.920.91.0
Beta Blockers36.746.542.8*55.554.1-1.4
Calcium Channel Blockers23.443.0*44.838.839.30.6
Estrogens37.541.4*47.141.043.72.7
NSAIDS52.867.2*73.065.366.51.2
Opioids55.436.4*82.653.357.03.7
Oral Hypoglycemic8.5*13.611.77.18.91.8
Proton Pump Inhibitors22.932.8*37.832.631.0-1.6
Skeletal Muscle Relaxants26.537.4*55.640.145.35.3
Statins31.5*49.143.642.244.32.1
Triptans27.434.641.240.6*51.210.5
Urinary Incontinence29.643.2*53.052.452.40.0
Average33.540.848.843.244.81.6
  1. Δindicates the change between adding the PICO features to the baseline logistic regression classifier (LR)
  2. *indicate best performance per review